^ January  191  ™" }  AmeHcan  Pharmaceutical  Association.  43 
the  indications  are  that  the  scope  of  the  forthcoming  Pharmacopoeia 
will  again  represent  the  views  of  but  a  limited  number  of  individuals. 
As  an  indication  of  the  opinions  held  by  the  better  informed 
medical  men  he  quoted  Dr.  Abraham  Jacobi,  the  Nestor  of  American 
physicians,  who  in  discussing  the  content  of  the  present  Pharmaco- 
poeia deplored  the  fact  that  the  makers  of  the  Pharmacopoeia  were 
not  willing  to  restrict  the  book  to  the  best  remedies  only. 
Dr.  W.  M.  Barton  seconded  the  remarks  made  by  Dr.  Hunt  and 
asserted  that  he  had  also  come  to  the  conclusion  that  there  are  two 
diametrically  opposed  opinions  regarding  the  scope  of  the  Pharmaco- 
poeia and  was  satisfied  that  the  book  cannot,  as  it  now  stands,  be 
accepted  by  medical  men  as  a  guide.  He  suggested  the  possibility 
of  limiting  the  medical  recognition  of  drugs  by  introducing  a  fair 
statement  of  the  physiological  action  of  the  substance  with  each 
description. 
Dr.  Wiley,  in  closing  the  discussion,  expressed  himself  satisfied 
with  the  feast  of  oratory  that  had  been  supplied  to  the  members  of 
the  Cit}^  of  Washington  Branch  and  their  guests,  and  felt  sure  that 
nothing  that  he  could  add  would  tend  to  increase  the  appreciation 
of  the  importance  of  revising  the  Pharmacopoeia  of  the  United  States 
along  the  lines  laid  down  by  the  United  States  Pharmacopoeial 
Convention.  M.  T.  Wilbert,  Secretary. 
REPORT  OF  THE  CITY  OF  WASHINGTON  BRANCH,  COMMITTEE  ON  THE 
JOURNAL  OF  THE  AMERICAN  PHARMACEUTICAL  ASSOCIATION, 
Your  Committee,  appointed  to  consider  the  paper  by  Mr.  Joseph 
W.  England  entitled  The  Journal  of  the  American  Pharuiaceutical 
Association,"  greatly  regrets  to  announce  that,  since  its  appointment 
at  the  October  meeting  of  this  Branch,  the  American  Pharmaceutical 
Association  has  sustained  a  serious  and  irreparable  loss  in  the  death 
of  Prof.  C.  S.  N.  Hallberg,  the  editor  of  the  Bulletin  and  the  chief 
Editor-elect  of  the  proposed  journal.  This  untimely  death  greatly 
complicates  the  problems  involved  in  the  launching  of  the  new 
journal.  While  your  committee  was  not  specifically  instructed  to 
consider  anytliing  but  tlic  communication  above  referred  to,  it 
nevertheless  feels  that  the  occasion  is  an  unusual  one  and  that  the 
late  Editor's  long  years  of  disinterested  service  to  pharmacy,  and 
particularly  the  American  Pharmaceutical  Association,  merit  special 
recognition. 
Your  Committee  would,  therefore,  respectfully  recommend  the 
adoption  of  the  following  preamble  and  resolutions : 
